Benjamin van der Woerd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Benjamin van der Woerd has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Michael M. Johns
Caruso Department of Otolaryngology‐Head & Neck Surgery Keck School of Medicine of the University of Southern California Los Angeles California USA
3 shared publicationsKarla O'DEll
Caruso Department of Otolaryngology‐Head & Neck Surgery Keck School of Medicine of the University of Southern California Los Angeles California USA
2 shared publicationsLauren Timmons Sund
Department of Otolaryngology-Head & Neck Surgery, University of Southern California, Los Angeles, California
2 shared publications- Stephanie Danielle MacNeil
Department of Otolaryngology—Head and Neck Surgery, Western University, London, ON, Canada
2 shared publications Ana-Maria Misariu
Division of Otolaryngology—Head & Neck Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada
1 shared publication- Anthony Charles Nichols
Department of Otolaryngology—Head and Neck Surgery, Western University, London, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 7 (1) , 13
Tracheal Rupture Secondary to an Iatrogenic Esophageal Perforation Presenting with Neck Insufflation on Valsalva: A Case Report
Background: Tracheal rupture is a rare, life-threatening condition that may follow blunt trauma, intubation, and, less commonly, esophageal instrumentation. The diagnosis may be challenging due to the subtle, delayed, and wide variety of symptoms. We present a unique case of delayed tracheal rupture secondary to iatrogenic esophageal perforation, presenting months later with a cervical neck insufflation on Valsalva, a novel clinical sign that has not been previously described in the literature. Case Presentation: A 44-year-old male initially presented with esophageal food impactation. Following endoscopic removal attempts, he developed signs consistent with esophageal perforation and was managed conservatively. In follow-up, he reported persistent neck discomfort, facial numbness, and the ability to insufflate the right side of his neck while doing a Valsalva. Flexible bronchoscopy and retrospective review of imaging revealed a proximal posterior tracheal defect, initially misinterpreted as a tracheal diverticulum. Surgical exploration confirmed a 6 cm dehiscence between the membranous trachea and the anterior wall of the esophagus. The defect was repaired using regional muscle flaps with tissue sealant reinforcement. Postoperatively, the patient had complete symptom resolution and no recurrence of neck insufflation. Conclusions: The case underscores the importance of maintaining a high index of suspicion for tracheal injury in patients with persistent or atypical symptoms following esophageal perforation or instrumentation. To our knowledge, we have described a novel clinical finding of neck insufflation upon Valsalva for diagnosing tracheal rupture.
- 2 March 2026
- Published by MDPI AG in Journal of Otorhinolaryngology, Hearing and Balance Medicine
- Vol. 7 (1) , 13
Open AccessTracheal Rupture Secondary to an Iatrogenic Esophageal Perforation Presenting with Neck Insufflation on Valsalva: A Case Report
Background: Tracheal rupture is a rare, life-threatening condition that may follow blunt trauma, intubation, and, less commonly, esophageal instrumentation. The diagnosis may be challenging due to the subtle, delayed, and wide variety of symptoms. We present a unique case of delayed tracheal rupture secondary to iatrogenic esophageal perforation, presenting months later with a cervical neck insufflation on Valsalva, a novel clinical sign that has not been previously described in the literature. Case Presentation: A 44-year-old male initially presented with esophageal food impactation. Following endoscopic removal attempts, he developed signs consistent with esophageal perforation and was managed conservatively. In follow-up, he reported persistent neck discomfort, facial numbness, and the ability to insufflate the right side of his neck while doing a Valsalva. Flexible bronchoscopy and retrospective review of imaging revealed a proximal posterior tracheal defect, initially misinterpreted as a tracheal diverticulum. Surgical exploration confirmed a 6 cm dehiscence between the membranous trachea and the anterior wall of the esophagus. The defect was repaired using regional muscle flaps with tissue sealant reinforcement. Postoperatively, the patient had complete symptom resolution and no recurrence of neck insufflation. Conclusions: The case underscores the importance of maintaining a high index of suspicion for tracheal injury in patients with persistent or atypical symptoms following esophageal perforation or instrumentation. To our knowledge, we have described a novel clinical finding of neck insufflation upon Valsalva for diagnosing tracheal rupture.
- Open Access
- 4 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1583-1587
Alginate Therapy for Gastroesophageal Reflux in Pregnancy: A Scoping Review
Objective: Alginate therapies are a promising option for managing gastroesophageal reflux (GERD), but most treatments are not recommended during pregnancy. This scoping review aimed to summarize the current outcomes research on the use of alginate therapy for treating GERD during pregnancy. Data Sources: EMBASE, MEDLINE, CINAHL, and Web of Science were searched from database inception to November 1, 2024. Reference lists of included studies were also searched. Review Methods: We included randomized controlled trials (RCTs) and non‐randomized studies evaluating alginate use in pregnant individuals with GERD. Screening and data extraction were performed by three reviewers in duplicate. Extracted data included study design, location, population, study group allocation, and clinical outcomes. Descriptive statistics were calculated using Microsoft Excel. Results: Two RCTs and two prospective cohort studies met the inclusion criteria. Of the two RCTs identified, one evaluated an alginate formulation against a proton pump inhibitor (PPI), and the other against a magnesium–aluminum antacid. Cohort studies reported investigator‐ and patient‐rated treatment success at 89.7% and 90.0%, respectively, with 92.2% of participants having symptom relief within 20 min. Similar improvements in heartburn intensity and frequency were found when comparing alginates and antacids. Few maternal adverse effects were reported, and no fetal or neonatal outcomes were related to treatment. Safety profiles of alginates were comparable to PPIs and antacids. Conclusion: Current literature on alginate therapy in pregnant women may suggest potential for symptom relief and favorable tolerability, but current evidence is limited by the few available prospective studies. Level of Evidence: N/A.
- 4 December 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1583-1587
Open AccessAlginate Therapy for Gastroesophageal Reflux in Pregnancy: A Scoping Review
Objective: Alginate therapies are a promising option for managing gastroesophageal reflux (GERD), but most treatments are not recommended during pregnancy. This scoping review aimed to summarize the current outcomes research on the use of alginate therapy for treating GERD during pregnancy. Data Sources: EMBASE, MEDLINE, CINAHL, and Web of Science were searched from database inception to November 1, 2024. Reference lists of included studies were also searched. Review Methods: We included randomized controlled trials (RCTs) and non‐randomized studies evaluating alginate use in pregnant individuals with GERD. Screening and data extraction were performed by three reviewers in duplicate. Extracted data included study design, location, population, study group allocation, and clinical outcomes. Descriptive statistics were calculated using Microsoft Excel. Results: Two RCTs and two prospective cohort studies met the inclusion criteria. Of the two RCTs identified, one evaluated an alginate formulation against a proton pump inhibitor (PPI), and the other against a magnesium–aluminum antacid. Cohort studies reported investigator‐ and patient‐rated treatment success at 89.7% and 90.0%, respectively, with 92.2% of participants having symptom relief within 20 min. Similar improvements in heartburn intensity and frequency were found when comparing alginates and antacids. Few maternal adverse effects were reported, and no fetal or neonatal outcomes were related to treatment. Safety profiles of alginates were comparable to PPIs and antacids. Conclusion: Current literature on alginate therapy in pregnant women may suggest potential for symptom relief and favorable tolerability, but current evidence is limited by the few available prospective studies. Level of Evidence: N/A.
- Open Access
- 1 September 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Evaluating the Efficacy of Large Language Models for Dizzy History Taking and Peripheral Vestibular Disorder Diagnosis
Importance: Vertigo accounts for one of the most frequent presenting symptoms in primary care. However, complexities in differential diagnoses and reliance on clinical history contribute to frequent specialist referrals and diagnostic delays. Large language models (LLMs), like LLaMA-3.1-8B, offer new potential for assisting in clinical decision-making. Objective: To assess the utility of a small-scale, open-source LLM in diagnosing peripheral vestibular disorders (PVDs), and evaluate the impact of synthetic data augmentation on diagnostic accuracy. Design: Retrospective chart review. Setting/Participants: A retrospective analysis included adult patients presenting with dizziness to a neuro-otologist at St. Joseph’s Healthcare Hamilton between 2018 and 2023. The dataset comprised 100 clinical cases, supplemented with 40 synthetic cases generated using GPT-4. The LLaMA-3.1-8B model was evaluated on the clinical, synthetic, and combined datasets. Diagnostic reasoning approaches, including chain-of-thought reasoning and multi-shot prompting, were employed to optimize model performance. Main Outcome Measures: Metrics for evaluation included top 1 and top 3 diagnostic accuracy, Cohen’s kappa for inter-rater agreement, and accuracy in predicting symptom laterality. Results: The LLaMA-3.1-8B model achieved a top 1 diagnostic accuracy of 60.7% and a top 3 accuracy of 71.4% in the combined dataset. The most frequent diagnosis was Meniere’s disease (55.7%), followed by vestibular migraines (9.3%) and labyrinthitis (9.3%). Diagnostic accuracy was highest for benign paroxysmal positional vertigo (90%), followed by Meniere’s disease (80.8%). Less common conditions, such as superior canal dehiscence syndrome and vestibular paroxysmia, exhibited lower diagnostic accuracies. Cohen’s kappa indicated substantial agreement for symptom side prediction (κ = 0.96) and moderate agreement for diagnosis (κ = 0.41) in the combined dataset. Conclusions and Relevance: The LLaMA-3.1-8B model demonstrated promising accuracy in diagnosing PVDs. The model’s performance highlights its potential to serve as a high-yield screening tool for primary care physicians and general otolaryngologists.
- 1 September 2025
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Open AccessEvaluating the Efficacy of Large Language Models for Dizzy History Taking and Peripheral Vestibular Disorder Diagnosis
Importance: Vertigo accounts for one of the most frequent presenting symptoms in primary care. However, complexities in differential diagnoses and reliance on clinical history contribute to frequent specialist referrals and diagnostic delays. Large language models (LLMs), like LLaMA-3.1-8B, offer new potential for assisting in clinical decision-making. Objective: To assess the utility of a small-scale, open-source LLM in diagnosing peripheral vestibular disorders (PVDs), and evaluate the impact of synthetic data augmentation on diagnostic accuracy. Design: Retrospective chart review. Setting/Participants: A retrospective analysis included adult patients presenting with dizziness to a neuro-otologist at St. Joseph’s Healthcare Hamilton between 2018 and 2023. The dataset comprised 100 clinical cases, supplemented with 40 synthetic cases generated using GPT-4. The LLaMA-3.1-8B model was evaluated on the clinical, synthetic, and combined datasets. Diagnostic reasoning approaches, including chain-of-thought reasoning and multi-shot prompting, were employed to optimize model performance. Main Outcome Measures: Metrics for evaluation included top 1 and top 3 diagnostic accuracy, Cohen’s kappa for inter-rater agreement, and accuracy in predicting symptom laterality. Results: The LLaMA-3.1-8B model achieved a top 1 diagnostic accuracy of 60.7% and a top 3 accuracy of 71.4% in the combined dataset. The most frequent diagnosis was Meniere’s disease (55.7%), followed by vestibular migraines (9.3%) and labyrinthitis (9.3%). Diagnostic accuracy was highest for benign paroxysmal positional vertigo (90%), followed by Meniere’s disease (80.8%). Less common conditions, such as superior canal dehiscence syndrome and vestibular paroxysmia, exhibited lower diagnostic accuracies. Cohen’s kappa indicated substantial agreement for symptom side prediction (κ = 0.96) and moderate agreement for diagnosis (κ = 0.41) in the combined dataset. Conclusions and Relevance: The LLaMA-3.1-8B model demonstrated promising accuracy in diagnosing PVDs. The model’s performance highlights its potential to serve as a high-yield screening tool for primary care physicians and general otolaryngologists.
- Open Access
- 1 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0325803
Evaluation of large language models as a diagnostic tool for medical learners and clinicians using advanced prompting techniques
Background: Large language models (LLMs) have demonstrated capabilities in natural language processing and critical reasoning. Studies investigating their potential use as healthcare diagnostic tools have largely relied on proprietary models like ChatGPT and have not explored the application of advanced prompt engineering techniques. This study aims to evaluate the diagnostic accuracy of three open-source LLMs and the role of prompt engineering using clinical scenarios. Methods: We analyzed the performance of three open-source LLMs—llama-3.1-70b-versatile, llama-3.1-8b-instant, and mixtral-8x7b-32768—using advanced prompt engineering when answering Medscape Clinical Challenge questions. Responses were recorded and evaluated for correctness, accuracy, precision, specificity, and sensitivity. A sensitivity analysis was conducted presenting the three LLMs with basic prompting challenge questions and excluding cases with visual assets. Results were compared with previously published performance data on GPT-3.5. Results: Llama-3.1-70b-versatile, llama-3.1-8b-instant, and mixtral-8x7b-32768 achieved correct responses in 79%, 65%, and 62% of cases, respectively, outperforming GPT-3.5 (74%). Diagnostic accuracy, precision, sensitivity, and specificity responses all outperformed those previously reported for GPT-3.5. Results generated using advanced prompting strategies were superior to those based on basic prompting. Sensitivity analysis revealed similar trends when cases with visual assets were excluded. Discussion: Using advanced prompting techniques, LLMs can generate clinically accurate responses. The study highlights the limitations of proprietary models like ChatGPT, particularly in terms of accessibility and reproducibility due to version deprecation. Future research should employ prompt engineering techniques and prioritize the use of open-source models to ensure research replicability.
- 1 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0325803
Open AccessEvaluation of large language models as a diagnostic tool for medical learners and clinicians using advanced prompting techniques
Background: Large language models (LLMs) have demonstrated capabilities in natural language processing and critical reasoning. Studies investigating their potential use as healthcare diagnostic tools have largely relied on proprietary models like ChatGPT and have not explored the application of advanced prompt engineering techniques. This study aims to evaluate the diagnostic accuracy of three open-source LLMs and the role of prompt engineering using clinical scenarios. Methods: We analyzed the performance of three open-source LLMs—llama-3.1-70b-versatile, llama-3.1-8b-instant, and mixtral-8x7b-32768—using advanced prompt engineering when answering Medscape Clinical Challenge questions. Responses were recorded and evaluated for correctness, accuracy, precision, specificity, and sensitivity. A sensitivity analysis was conducted presenting the three LLMs with basic prompting challenge questions and excluding cases with visual assets. Results were compared with previously published performance data on GPT-3.5. Results: Llama-3.1-70b-versatile, llama-3.1-8b-instant, and mixtral-8x7b-32768 achieved correct responses in 79%, 65%, and 62% of cases, respectively, outperforming GPT-3.5 (74%). Diagnostic accuracy, precision, sensitivity, and specificity responses all outperformed those previously reported for GPT-3.5. Results generated using advanced prompting strategies were superior to those based on basic prompting. Sensitivity analysis revealed similar trends when cases with visual assets were excluded. Discussion: Using advanced prompting techniques, LLMs can generate clinically accurate responses. The study highlights the limitations of proprietary models like ChatGPT, particularly in terms of accessibility and reproducibility due to version deprecation. Future research should employ prompt engineering techniques and prioritize the use of open-source models to ensure research replicability.
- Open Access
- 4 July 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (7)
Clinical applications of large language models in medicine and surgery: A scoping review
Objective: To provide a comprehensive overview of the current use of large language models in clinical medicine and surgery, with emphasis on model characteristics, clinical applications, and readiness for adoption. Methods: A scoping review of studies on the use of large language models in clinical medicine and surgery was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)-scoping review and JBI methodology (protocol registration: 10.37766/inplasy2025.3.0102). A comprehensive search of EMBASE, PubMed, CINAHL, and IEEE Xplore identified 3313 articles published between 2018 and 2023. After screening of articles and full-text review, 156 studies were included. Data were extracted for study type, sample size, clinical specialty, model architecture, training methods, application purpose, and performance metrics. Descriptive analyses were performed. Results: Most studies were proof-of-concept studies (55.8%) or clinical trials (21.2%), with a steady rise in publications since 2022. Large language models were most frequently used for data extraction (69.9%), followed by clinical recommendations (11.5%), report generation (9.0%), and patient-facing chatbots (7.1%). Proprietary models were used in 57.7% of the studies, whereas 39.7% used open-source models. ChatGPT-3.5, ChatGPT-4, and Bidirectional Encoder Representations from Transformers (BERT) were the most commonly reported models. Only 25.0% of the studies reported models as ready for clinical use, whereas 67.9% stated that the models required further validation. F-score (30.8%) and area under the curve (15.4%) were the most common performance metrics; 10.9% of the studies used expert opinion for validation. Conclusions: Large language models are increasingly being used in clinical medicine. Although most applications focus on data extraction and summarization, emerging studies are beginning to explore higher-level tasks such as clinical decision-making and multidisciplinary simulation. Significant heterogeneity continues to exist in model architecture, evaluation methods, and reporting standards. Further standardization is needed to develop transparent evaluation frameworks and ensure safe, reliable integration of large language models into complex clinical workflows.
- 4 July 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (7)
Open AccessClinical applications of large language models in medicine and surgery: A scoping review
Objective: To provide a comprehensive overview of the current use of large language models in clinical medicine and surgery, with emphasis on model characteristics, clinical applications, and readiness for adoption. Methods: A scoping review of studies on the use of large language models in clinical medicine and surgery was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)-scoping review and JBI methodology (protocol registration: 10.37766/inplasy2025.3.0102). A comprehensive search of EMBASE, PubMed, CINAHL, and IEEE Xplore identified 3313 articles published between 2018 and 2023. After screening of articles and full-text review, 156 studies were included. Data were extracted for study type, sample size, clinical specialty, model architecture, training methods, application purpose, and performance metrics. Descriptive analyses were performed. Results: Most studies were proof-of-concept studies (55.8%) or clinical trials (21.2%), with a steady rise in publications since 2022. Large language models were most frequently used for data extraction (69.9%), followed by clinical recommendations (11.5%), report generation (9.0%), and patient-facing chatbots (7.1%). Proprietary models were used in 57.7% of the studies, whereas 39.7% used open-source models. ChatGPT-3.5, ChatGPT-4, and Bidirectional Encoder Representations from Transformers (BERT) were the most commonly reported models. Only 25.0% of the studies reported models as ready for clinical use, whereas 67.9% stated that the models required further validation. F-score (30.8%) and area under the curve (15.4%) were the most common performance metrics; 10.9% of the studies used expert opinion for validation. Conclusions: Large language models are increasingly being used in clinical medicine. Although most applications focus on data extraction and summarization, emerging studies are beginning to explore higher-level tasks such as clinical decision-making and multidisciplinary simulation. Significant heterogeneity continues to exist in model architecture, evaluation methods, and reporting standards. Further standardization is needed to develop transparent evaluation frameworks and ensure safe, reliable integration of large language models into complex clinical workflows.
- 17 March 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (8) , 2838-2845
A National Survey on Retrograde Cricopharyngeus Dysfunction Practice Patterns Among Laryngologists
Objective: Retrograde cricopharyngeus dysfunction (RCPD) is characterized by the inability to belch, abdominal bloating, and distension, as well as socially awkward gurgling noises and excessive flatulence. The use of various diagnostic tools remains variable, while the national incidence of preference among laryngologists toward management remains unknown. This study aims to analyze trends and practice patterns in the diagnostic workup and management of RCPD among academic laryngologists. By doing so, our goal is to elucidate clinical decision‐making patterns and treatment outcomes associated with the management strategies for RCPD.Methods: An electronic survey was sent to 184 academic laryngologists. The survey assessed RCPD topics related to patient demographics, clinical characteristics, knowledge and experience levels, perceived importance of historical and physical factors in diagnosis, diagnostic workup and utility, the effectiveness of different management approaches, and specifics of botulinum toxin (BT) injection practices.Results: Of the 87 (47.2%) laryngologists who responded to the survey, 75.9% have heard of RCPD before. The most common management approaches were BT injections (79.2%) and cricopharyngeus myotomy (11.3%). The mean amount of BT injected by laryngologists was 59 units.Conclusion: The survey demonstrates that RCPD is likely conceived as a clinical diagnosis among practicing laryngologists. While BT injections are done more frequently and are perceived to be effective, the role of myotomy of the cricopharyngeus remains variable.Level of Evidence: 5
- 17 March 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (8) , 2838-2845
A National Survey on Retrograde Cricopharyngeus Dysfunction Practice Patterns Among Laryngologists
Objective: Retrograde cricopharyngeus dysfunction (RCPD) is characterized by the inability to belch, abdominal bloating, and distension, as well as socially awkward gurgling noises and excessive flatulence. The use of various diagnostic tools remains variable, while the national incidence of preference among laryngologists toward management remains unknown. This study aims to analyze trends and practice patterns in the diagnostic workup and management of RCPD among academic laryngologists. By doing so, our goal is to elucidate clinical decision‐making patterns and treatment outcomes associated with the management strategies for RCPD.Methods: An electronic survey was sent to 184 academic laryngologists. The survey assessed RCPD topics related to patient demographics, clinical characteristics, knowledge and experience levels, perceived importance of historical and physical factors in diagnosis, diagnostic workup and utility, the effectiveness of different management approaches, and specifics of botulinum toxin (BT) injection practices.Results: Of the 87 (47.2%) laryngologists who responded to the survey, 75.9% have heard of RCPD before. The most common management approaches were BT injections (79.2%) and cricopharyngeus myotomy (11.3%). The mean amount of BT injected by laryngologists was 59 units.Conclusion: The survey demonstrates that RCPD is likely conceived as a clinical diagnosis among practicing laryngologists. While BT injections are done more frequently and are perceived to be effective, the role of myotomy of the cricopharyngeus remains variable.Level of Evidence: 5
- 8 August 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5021-5027
Prospective Outcomes After Serial Platelet‐Rich Plasma (PRP) Injection in Vocal Fold Scar and Sulcus
Objective: Vocal fold scar and sulcus pose significant treatment challenges with no current optimal treatment. Platelet‐rich plasma (PRP), an autologous concentration of growth factors, holds promise for regenerating the superficial lamina propria. This study aims to evaluate the potential benefits of serial PRP injections on mucosal wave restoration and vocal function.Methods: In a prospective clinical trial across two institutions, patients with vocal fold scar underwent four serial PRP injections, one month apart. Blinded independent laryngologists and expert listeners used pretreatment and one‐month post‐fourth injection videostroboscopy and CAPE‐V assessments to evaluate mucosal wave and voice quality changes, respectively. Additionally, patient reported outcome measures (PROMs) were evaluated.Results: In the study, 15 patients received 55 PRP injections without adverse effects. Eight patients (53.3%) had mild, three patients (20%) had moderate, and four patients (26.7%) had severe scar.There was an average reduction of 8.7 points in post‐treatment VHI‐10 scores (p = 0.007). The raters observed an improvement in post‐treatment voice in 73.4% of cases, and CAPE‐V scores showed a reduction of 18.8 points on average (p = 0.036). The videostroboscopic VALI ratings showed an improvement in mucosal wave rating from 2.0 to 4.0. On average, the raters perceived the post‐PRP exams to be better in 56.7% of cases.Conclusions: PRP has been validated as a safe autologous option for treatment of vocal fold scar. While results for mucosal wave and voice quality varied, there was a consistent improvement in PROMs.Level of Evidence: 3: Prospective cohort study, with blinded analysis Laryngoscope, 134:5021–5027, 2024
- 8 August 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 5021-5027
Prospective Outcomes After Serial Platelet‐Rich Plasma (PRP) Injection in Vocal Fold Scar and Sulcus
Objective: Vocal fold scar and sulcus pose significant treatment challenges with no current optimal treatment. Platelet‐rich plasma (PRP), an autologous concentration of growth factors, holds promise for regenerating the superficial lamina propria. This study aims to evaluate the potential benefits of serial PRP injections on mucosal wave restoration and vocal function.Methods: In a prospective clinical trial across two institutions, patients with vocal fold scar underwent four serial PRP injections, one month apart. Blinded independent laryngologists and expert listeners used pretreatment and one‐month post‐fourth injection videostroboscopy and CAPE‐V assessments to evaluate mucosal wave and voice quality changes, respectively. Additionally, patient reported outcome measures (PROMs) were evaluated.Results: In the study, 15 patients received 55 PRP injections without adverse effects. Eight patients (53.3%) had mild, three patients (20%) had moderate, and four patients (26.7%) had severe scar.There was an average reduction of 8.7 points in post‐treatment VHI‐10 scores (p = 0.007). The raters observed an improvement in post‐treatment voice in 73.4% of cases, and CAPE‐V scores showed a reduction of 18.8 points on average (p = 0.036). The videostroboscopic VALI ratings showed an improvement in mucosal wave rating from 2.0 to 4.0. On average, the raters perceived the post‐PRP exams to be better in 56.7% of cases.Conclusions: PRP has been validated as a safe autologous option for treatment of vocal fold scar. While results for mucosal wave and voice quality varied, there was a consistent improvement in PROMs.Level of Evidence: 3: Prospective cohort study, with blinded analysis Laryngoscope, 134:5021–5027, 2024
- 8 July 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (6) , 1440-1445
A Machine-Learning Algorithm for the Automated Perceptual Evaluation of Dysphonia Severity
- 8 July 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (6) , 1440-1445
A Machine-Learning Algorithm for the Automated Perceptual Evaluation of Dysphonia Severity
- 10 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 954-957
Local Reaction Causing Airway Compromise Following Vocal Fold Injection Augmentation with Carboxymethylcellulose
- 10 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 954-957
Local Reaction Causing Airway Compromise Following Vocal Fold Injection Augmentation with Carboxymethylcellulose
- 15 July 2022
- Published by Elsevier in Journal of Voice
- Vol. 38 (6) , 1531.e1-1531.e3
Cricothyroid Muscle Botulinum Toxin Chemodenervation to Treat Recalcitrant High-Pitched Functional Dysphonia in an Adult Male
- 15 July 2022
- Published by Elsevier in Journal of Voice
- Vol. 38 (6) , 1531.e1-1531.e3
Cricothyroid Muscle Botulinum Toxin Chemodenervation to Treat Recalcitrant High-Pitched Functional Dysphonia in an Adult Male